We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Ticker | Name | Price | Change | Change % | Volume |
---|---|---|---|---|---|
HOVR | New Horizon Aircraft Ltd | 1.37 | 0.65 | 90.28% | 2,971,546 |
SPEC | Spectaire Holdings Inc | 0.79 | 0.36155 | 84.39% | 12,453,189 |
LGHLW | Lion Group Holding Ltd | 0.0035 | 0.0007 | 25.00% | 328,896 |
NISN | NiSun International Enterprise Development Group Company Ltd | 4.02 | 0.65 | 19.29% | 352,695 |
SVRE | SaverOne 2014 Ltd | 0.5974 | 0.0774 | 14.88% | 2,230 |
CNEY | CN Energy Group Inc | 0.52 | 0.0604 | 13.14% | 3,311 |
SNSE | Sensei Biotherapeutics Inc | 0.7347 | 0.0844 | 12.98% | 1,269 |
RVYL | RYVYL Inc | 1.61 | 0.18 | 12.59% | 10,560 |
PRST | Presto Technologies Inc | 0.0999 | 0.0108 | 12.12% | 16,327,741 |
DRMA | Dermata Therapeutics Inc | 3.69 | 0.39 | 11.82% | 502 |
DERM | Journey Medical Corporation | 5.2499 | 0.5499 | 11.70% | 16,214 |
SHANGHAI, June 7, 2024 /PRNewswire/ -- Nisun International Enterprise Development Group Co., Ltd ("Nisun International" or the "Company") (Nasdaq: NISN), a technology and industry driven integrated supply chain solutions provider, today announced that it has achieved a significant breakthrough in its egg business following the Company stepping into the egg industry.
Transaction ensures Nestlé Health Science will continue to commercialize the product BRIDGEWATER, N.J., June 6, 2024 /PRNewswire/ -- Seres Therapeutics, Inc. (Nasdaq: MCRB), announced today that it has agreed to a non-binding memorandum of understanding with Nestlé Health Science in which Nestlé Health Science will acquire certain tangible and intangible assets associated with VOWST (fecal microbiota spores, live-brpk) capsules. This transaction, when completed, supersedes any prior agreements between Nestlé and Seres concerning VOWST. Nestlé Health Science has been the lead commercialization party for the product since its launch in June 2023 in the United States. This transaction will allow Nestlé Health Science ...
Novo Integrated Sciences, Inc. (NASDAQ: NVOS) (the “Company” or “Novo”), today announced the Company’s Board of Directors has approved an increase of up to $10 million maximum amount, from the previously announced up to $5 million maximum amount, for the repurchase of the Company's outstanding common stock from time to time in the open market at prevailing market prices or in privately negotiated transactions. The increased maximum amount available for purchase under the stock repurchase program is based on the amount, if any, of excess funds that may be generated from the pending program to monetize a Standby Letter of ...
CrowdStrike (Nasdaq: CRWD) today announced that the AI-native CrowdStrike Falcon® cybersecurity platform won five awards in the SC Awards Europe 2024 – the most of any vendor in this year’s competition. CrowdStrike won for Best Cloud Security Solution, Best Endpoint Solution, Best AI Solution, Best Threat Intelligence Technology and Best Incident Response Solution.
Rank | Ticker | Board Name | Posts (24h) |
---|---|---|---|
LWLG | Lightwave Logic Inc | 164 | |
COOP | Mr Cooper Group Inc | 49 | |
RSPI | RespireRx Pharmaceuticals Inc | 96 | |
4 | SPZI | SPOOZ Inc | 78 |
5 | IQST | iQSTEL Inc | 19 |
6 | VPLM | Voip Pal Com Inc | 22 |
Ticker | Name | Price | Change | Change % | Market Cap | Volume |
---|---|---|---|---|---|---|
BTC | Bitcoin | 69,412.08 | -1,351.94 | -1.91% | 1.36T | 5,089,995,367 |
ETH | Ethereum | 3,690.07 | -121.20 | -3.18% | 443.63B | 2,673,202,988 |
BNB | Binance Coin | 684.92 | -25.55 | -3.60% | 108.09B | 523,395,468 |
USDT | Tether USD | 0.99962 | 0.00001 | 0.00% | 97.8B | 274,992,819 |
SOL | Solana | 162.92 | -7.03 | -4.14% | 71.85B | 1,121,122,189 |
STETH | stETH | 3,674.93 | -134.05 | -3.52% | 36.04B | 13,461,977 |
USDC | USD Coin | 0.9999 | 0.0001 | 0.01% | 28.07B | 1,001,764,065 |
XRP | Ripple | 0.500 | -0.0214 | -4.10% | 27.3B | 449,534,168 |
TONCOIN | Wrapped TON Coin | 7.28 | -0.215596 | -2.88% | 25.25B | 227,431,331 |
DOGE | Dogecoin | 0.1484 | -0.01163 | -7.27% | 21.26B | 433,788,388 |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: 1-888-992-3836 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions